Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-19

Clinical Trial Update: Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant [NA]

View source ↗

Summary

A completed clinical trial investigating multivirus-specific T cells for treating infections after stem cell transplant; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Multivirus-specific T cells (AlloVir product)

Snippet

Sponsor: AlloVir | Conditions: Infection | NA | Status: COMPLETED | Results posted: 2021-07-19